Diamonds and Dogs

7/8/13

Natus Medical Inc. (BABY)

Natus Medical is not nourishing its investors today, down 13.37% at $12.38. The newborn care company saw its shares fall after disappointing preliminary revenue figures for the second quarter. Natus announced that it expects $81 million to $82 million in sales compared to its previous guidance of $86 million to $90 million; and well below analysts' forecast of $88.8 million. The company blamed a rapid drop-off in international sales for their lower forecast. Natus Medical shares are trading in middle of their 52-week range of $9.65-15.18.

Alcobra Ltd. (ADHD)

Alcobra shares aren't boring investors today, as they are up 15.5% at $7.90. This biopharmaceutical company, which focuses on the development and commercialization of various drugs for the treatment of neurological disturbance, saw a rise in their shares today due to an initiated BUY from the research firm Aegis Capital. The newly added Nasdaq company saw their shares rise close to their 52-week high of $8.30.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.